menu
    • menu

    Company profile for Rebiotix

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Rebiotix Inc is a clinical stage biotechnology company founded to revolutionize the treatment of debilitating gastrointestinal (GI) diseases by harnessing the power of the human microbiome.The company is on the forefront of an exciting potential medical breakthrough, our Microbiota Restoration Therapy

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RebiotixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2660 Patton Road Roseville, MN 55113 USA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rebiotix.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA's vaccine adcomm to review 1st fecal transplant for C. difficile infections
    FDA's vaccine adcomm to review 1st fecal transplant for C. difficile infections

    08 Aug 2022

    // Zachary Brennan ENDPTS

    https://endpts.com/fdas-vaccine-adcomm-to-review-first-fecal-microbiota-transplant-to-treat-c-difficile-infections/

    Zachary Brennan ENDPTS
    08 Aug 2022
    Share Share
    Ferring presents data from five trials of RBX2660 demonstrating uniform efficacy
    Ferring presents data from five trials of RBX2660 demonstrating uniform efficacy

    29 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210929006015/it

    BUSINESSWIRE
    29 Sep 2021
    Share Share
    Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota
    Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota

    13 May 2021

    // PRESS RELEASE

    https://www.ferring.com/ferring-and-rebiotix-to-present-landmark-data-for-investigational-microbiota-based-live-biotherapeutic-rbx2660-at-digestive-disease-week-ddw-2021/

    PRESS RELEASE
    13 May 2021
    Share Share
    Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based
    Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based

    16 Feb 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210216006205/en

    BUSINESSWIRE
    16 Feb 2021
    Share Share
    Rebiotix & Ferring Announce World’s First With Positive Pivotal Ph3 Data RBX2660
    Rebiotix & Ferring Announce World’s First With Positive Pivotal Ph3 Data RBX2660

    06 May 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200506005454/en

    BUSINESSWIRE
    06 May 2020
    Share Share
    After big 2016 setback, field of microbiome-based drugs gets injection promise
    After big 2016 setback, field of microbiome-based drugs gets injection promise

    06 May 2020

    // Natalie Grover ENDPTS

    https://endpts.com/after-big-2016-setback-field-of-microbiome-based-drugs-gets-injection-of-promise-with-positive-signal-from-rebiotix-pivotal-study/

    Natalie Grover ENDPTS
    06 May 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search